Galectin Therapeutics Inc.GALTNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-0.58
Operating CF/Share$-0.48
Free CF/Share$-0.48
Cash/Share$0.18
Book Value/Share$-1.95
Tangible Book/Share$-1.95
Equity/Share$-1.95
Interest Debt/Share$2.02
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$182.46M
Enterprise Value$293.25M
P/E Ratio-4.87P/S Ratio0.00P/OCF Ratio-5.93
P/FCF Ratio-5.96
P/B Ratio-1.45P/TB Ratio-1.45
EV/Sales0.00EV/EBITDA-9.72
Graham Valuation
Graham Number--
Graham Net-Net$-1.97
Profitability
Earnings Yield-20.53%FCF Yield-16.78%ROE32.59%ROIC2298.74%Return on Tangible Assets-289.96%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity-0.98Debt/Assets9.51Debt/Market Cap0.67
Net Debt/EBITDA-3.67
Current Ratio0.09Interest Coverage-4.10xIncome Quality0.82Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding89425 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets-$125.30M
Working Capital-$123.72M
Invested Capital-$123.72M
Intangibles/Assets0.00%